Jerusalem Pharmaceuticals Past Earnings Performance
Past criteria checks 5/6
Jerusalem Pharmaceuticals has been growing earnings at an average annual rate of 11.7%, while the Pharmaceuticals industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 9.2% per year. Jerusalem Pharmaceuticals's return on equity is 13.6%, and it has net margins of 20.1%.
Key information
11.7%
Earnings growth rate
11.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 9.2% |
| Return on equity | 13.6% |
| Net Margin | 20.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Jerusalem Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 43 | 9 | 13 | 2 |
| 30 Jun 23 | 44 | 8 | 12 | 2 |
| 31 Mar 23 | 45 | 8 | 12 | 2 |
| 31 Dec 22 | 46 | 7 | 13 | 2 |
| 30 Sep 22 | 46 | 8 | 13 | 2 |
| 30 Jun 22 | 47 | 8 | 13 | 2 |
| 31 Mar 22 | 47 | 7 | 13 | 2 |
| 31 Dec 21 | 46 | 7 | 13 | 2 |
| 30 Sep 21 | 41 | 4 | 12 | 2 |
| 30 Jun 21 | 40 | 4 | 12 | 2 |
| 31 Mar 21 | 37 | 3 | 11 | 1 |
| 31 Dec 20 | 36 | 4 | 11 | 1 |
| 30 Sep 20 | 36 | 5 | 11 | 1 |
| 30 Jun 20 | 35 | 5 | 10 | 1 |
| 31 Mar 20 | 35 | 6 | 10 | 1 |
| 31 Dec 19 | 34 | 5 | 10 | 1 |
| 30 Sep 19 | 32 | 4 | 10 | 1 |
| 30 Jun 19 | 32 | 4 | 9 | 1 |
| 31 Mar 19 | 31 | 5 | 9 | 1 |
| 31 Dec 18 | 31 | 5 | 8 | 1 |
| 30 Sep 18 | 32 | 6 | 9 | 1 |
| 30 Jun 18 | 28 | 6 | 9 | 1 |
| 31 Mar 18 | 30 | 6 | 9 | 1 |
| 31 Dec 17 | 30 | 6 | 8 | 1 |
| 30 Sep 17 | 28 | 5 | 7 | 1 |
| 30 Jun 17 | 30 | 5 | 7 | 1 |
| 31 Mar 17 | 28 | 5 | 7 | 1 |
| 31 Dec 16 | 26 | 3 | 7 | 1 |
| 30 Sep 16 | 24 | 1 | 9 | 1 |
| 30 Jun 16 | 24 | 1 | 8 | 1 |
| 31 Mar 16 | 24 | 1 | 8 | 1 |
| 31 Dec 15 | 26 | 2 | 8 | 1 |
| 30 Sep 15 | 26 | 4 | 7 | 1 |
| 30 Jun 15 | 26 | 3 | 8 | 1 |
| 31 Mar 15 | 26 | 3 | 8 | 1 |
| 31 Dec 14 | 24 | 2 | 8 | 1 |
| 30 Sep 14 | 24 | 1 | 7 | 1 |
| 30 Jun 14 | 22 | 1 | 7 | 1 |
| 31 Mar 14 | 21 | 1 | 8 | 1 |
| 31 Dec 13 | 22 | 2 | 7 | 1 |
| 30 Sep 13 | 23 | 2 | 7 | 0 |
| 30 Jun 13 | 22 | 2 | 7 | 0 |
Quality Earnings: JPH has high quality earnings.
Growing Profit Margin: JPH's current net profit margins (20.1%) are higher than last year (16.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JPH's earnings have grown by 11.7% per year over the past 5 years.
Accelerating Growth: JPH's earnings growth over the past year (12.2%) exceeds its 5-year average (11.7% per year).
Earnings vs Industry: JPH earnings growth over the past year (12.2%) exceeded the Pharmaceuticals industry 7.7%.
Return on Equity
High ROE: JPH's Return on Equity (13.6%) is considered low.